x

Research

Research

Research Map & Interests

  1. Evaluation of side effects of medicines in people with hypertension
  2. Quality of life of people with hypertension
  3. Effectiveness of non-pharmacological treatments in controlling blood pressure 
  4. Blood pressure crises
  5. Prevention (primary, secondary, tertiary) in hypertension
  6. Lifestyle in patients with hypertension and effective factors
  7. Metabolic syndrome and hypertension
  8. The effect of high blood pressure on various diseases
  9. Pregnancy and high blood pressure
  10. Sleep disorders and high blood pressure
  11. Self-care in patients with hypertension
  12. Causes of lack of control of hypertension in society (women, men, the elderly ...)
  13. Evaluation of complications and disabilities caused by hypertension and determining strategies to improve complications
  14. Mood disorders and high blood pressure
  15. Invasive treatments to control high blood pressure
  16. Resistant hypertension
  17. Strategies to reduce the complications of hypertension
  18. Strategies to reduce salt consumption in society
  19. Investigation of factors affecting the development of hypertension
  20. Assessing the status of awareness, control and treatment of blood pressure
     

Projects

  1. Determining the incidence of non-communicable and communicable diseases, recurrence rate, disease consequences, and mortality in a five-year prospective longitudinal cohort study based on a hospital registry of COVID 19 patients in Isfahan (Defeat COVID 19) Cohort Study.
  2. Screening of Hypertension in Adolescents to Achieve a map to the Implementation of a Cohort Study on Adolescents with Hypertension Background in Isfahan Province.
  3. Development of national clinical practice guidelines for the Management, Diagnosis and Treatment of Acute Coronary Syndromes.
  4. Comparing Effectiveness and Safety of Synchronized Electrical Cardioversion by ZOLL and SAIRAN- Electroshocks in Patients with Atrial Fibrillation: A Non-Inferiority Single Blinded Randomized Clinical Trial.
  5. Assessing the Impact of Training general practitonars the latest hypertension international and national Guidelines on Controlling their Under-Treatment Hypertensive Patients.
  6. Anti-anginal and anti-ischemic effects of Empagliflozin in in diabetic patients with refractory angina.
  7. Successful & unsuccessful weight control in adolescents with obesity: Qualitative research in Isfahan.
  8. Determining the prevalence of premature coronary heart disease and its risk factors according to different ethnicities and religions in Iran and developing a biobank for epigenetic studies
  9. Chronic Ischemic Cardiovascular Disease (CICD) Long-Term Registry.
  10. Percutaneous Coronary Intervention’s (PCI) Registry in Esfahan Iranian Registry of Percutaneous Coronary Interventions (Pilot).
  11. Evaluation of the contributing and inhibitory factors of the implementation of the national guide for prevention, evaluation and treatment of hypertension in the medical team of Isfahan University of Medical Sciences.
  12. Effect of selenium supplementation on pre inflammatory markers in subjects with mets
  13. Updating Preparation Iranian Recommendations on Prevention, Evaluation and Management of High Blood Pressure (Guideline).
  14. Launching the first medical, research and educational center for high blood pressure in Isfahan.
  15. Validation of feed frequency questionnaire to assessment sodium intake and the share of food groups in receiving it in two age groups of adults, children and adolescents in Isfahan.
  16. Evaluation of the effect of self-care programs and localized treatment strategies on improving blood pressure control in Iran.
  17. Preparation of the First Iranian Recommendations on Prevention, Evaluation and Management of High Blood Pressure (Summary)
  18. Evaluation of urinary sodium in adult & children in Isfahan urban area.
  19. Designing a sensitization model for community and high-risk groups to reducing salt intake in Isfahan.
  20. Evaluation of sodium, chlorine and salt amounts in the main food sources of salt in Iranian society.
  21. Preparation of the First Iranian Recommendations on Prevention, Evaluation and Management of High Blood Pressure (Guideline).
  22. Improving the level of health in high risk and poor control employees (patients with high blood pressure) in Mobarakeh Steel Company (Complementary Plan)
  23. Assessment of salt intake per day based on the amount of urinary sodium chloride excretion in 24 hours in people older than 18 years of age in Isfahan and Najafabad.
  24. Assessment of the effect of treating cardiovascular risk factors on the risk of cardiovascular incidence in hypertensive patients in Isfahan's Folad-Mobarakeh workers.
  25. Acute Coronary Events -A Multinational Survey of current managements Strategies
  26. Assessment of cardiovascular incidence rate following administration of Osvix compared to Plavix after coronary artery stenting.
  27. Comparison effectiveness of Acupuncture and Iranian bupropion in cessation of Smoking short (one month) and long term (12 months) abstinence.
  28. International smoking quit competition in 2006 (Quite & Win)
  29. Evaluation of national plan of the integrating for control HTN in the rural area of Isfahan.
  30. Comparative study of the effect of potassium salt and common salt on the blood pressure status of patients with hypertension
  31. The comparison of effect of low dose immediate release nicotinic acid with simvastatin on high level HDL-serum.
  32. Comparative Evaluation of Effects of Cardiac Rehabilitation on Morbidity and knowledge -Attitude-Practice (KAP) of Cardiac Patients About Cardiovascular Risk factors in a one Cohort study
  33. The Effect of Health courier on Improving the Awareness and Performance of Nursing Staff in Educational and Social Security Hospitals to Prevent and Control Non-Communicable Diseases
  34. Evaluation of short-term and long-term heart damage in patients with stroke 40-75 years’ old
  35. Healthy lifestyle for high-risk people in studying Isfahan healthy heart.
  36. International smoking quit competition in 2004. (Quite & Win)
  37. Evaluation of metoral effect on 30 days’ cardiovascular complications in patients with moderate to high cardiovascular risk who undergo non cardiac surgery
  38. Evaluation the relation between insulin resistance and restenosis after PTCA in non-diabetic ischemic patients
  39. Evaluation of early and late outcomes in patients with carotid artery disease treated by percutaneous carotid angioplasty and stenting in Isfahan
  40. Assessing the effect of educational interventions on the level of awareness of health care personnel regarding the control and treatment of cardiovascular and stroke diseases working in Isfahan, Najafabad and Arak health centers.
  41. A comparison of primary coronary angioplasty with streptokinase in acute myocardial infarction.
  42. Evaluation of the Comparison of Effectiveness and Side Effects of External Lovastatin and Lovastatin Manufactured by Domestic Pharmaceutical Companies.
  43. Prevention of Recurrent MI and stroke.
  44. Effect of metabolic syndrome score on atherosclerotic risk profile and coronary artery disease severity via angiography
  45. Evaluating the rate of LDL oxide on restenosis after doing angioplasty
  46. Evaluation the effect of treatment for chlamydia and helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndrome
  47. Evaluation of care and cost of acute stroke in Iran
  48. Assessment of myocardial perfusion imaging validity by SPECT method in diagnosis of significant coronary artery stenosis in comparison with "coronary angiography in Isfahan"
  49. Effect of metabolic syndrome score on atherosclerotic risk profile and coronary artery disease severity via angiography.
  50. Effect of estrogen on Maximal Walk Distance in patient with Intermittent Claudication.
  51. Assessment of serum Lp (a) level, fibrinogen, and anti-cardiolipin antibody in patients with recurring stenosis following PTCA.
  52. Evaluation of the trend of changes cardiovascular risk factors in people over 35 years old in three central cities of Iran.
  53. Evaluation of the level of awareness, performance and belief of general practitioners about the treatment of patients.
  54. Evaluation of the effect of nutritional interventions on increasing the awareness, attitude and nutritional performance of people in the community (healthy food project for a healthy society).
  55. Evaluation of the effect of hydrochlorothiazide and indapamide, foreign and Iranian ethanol in controlling blood pressure in people aged 25-75 years who refer to the blood pressure clinic of Isfahan Cardiovascular Research Center
  56. Health personnel training project in Isfahan, Najafabad, and Arak
  57. Healthy life for cardiovascular patients(HLCP)
  58. Healthy Life for Cardiovascular Patients Health Personal Education
  59. Trend of incidence, prevalence fatality, morbidity and mortality due to myocardial infarction and stroke in rural and urban areas of Isfahan, Najaf- Abad and Arak

PhD by Research

  • Trends of determinants on prevalence, awareness, treatment and control hypertension among the adults in Isfahan (2001-2015) and evaluation of the effect of expanded chronic care model on control and treatment and self-care. 

 

Prepared at Isfahan University of Medical Sciences